Advertisement
Neurology
Subscribe to Neurology
View Sample

FREE Email Newsletter

An App to Lead the Blind

August 1, 2013 10:02 am | by Inderscience Publishers | News | Comments

A smartphone app that keeps track of your location and distance walked from home or hotel and warns you when you are likely to be caught out after dark has been developed by researchers in Pakistan to help sufferers of the debilitating disease night blindness.

Researchers to Create Virtual Speech Therapist

July 30, 2013 9:56 am | by Kathy Matheson, Associated Press | News | Comments

Cyber-clinicians can be a crucial tool in overcoming the language disorder known as aphasia, experts say. While the verbal impairment can be life-long, health insurers only pay for a limited amount of therapy. Yet patients need to continuously practice their skills.

NeuroSigma wins an FDA green light for Phase III clinical trials

July 29, 2013 2:25 pm | by Mass Device | News | Comments

NeuroSigma is one step closer to bringing its epilepsy treatment to U.S. markets with FDA approval to begin its Phase III clinical studies. Currently only available for investigational use in the U.S., NeuroSigma's Monarch eTNS system is already on the shelves in Europe and Canada.

Advertisement

University Researches Effectiveness of Telehealth

July 29, 2013 11:27 am | by University of Salford | News | Comments

The University of Salford has carried out a systematic review of the literature to research the effectiveness of telehealth on clinical outcomes, cost effectiveness and patient experience. Telehealth allows patients to monitor long-term health conditions from home, reducing visits to a clinic or hospital.

Silky Brain Implants May Help Stop Spread of Epilepsy

July 29, 2013 10:15 am | by NIH/National Institute of Neurological Disorders and Stroke | News | Comments

Silk has walked straight off the runway and into the lab. According to a new study published in the Journal of Clinical Investigation, silk implants placed in the brain of laboratory animals and designed to release a specific chemical, adenosine, may help stop the progression of epilepsy.

Hacker Discussing Hacking Pacemakers Dies

July 27, 2013 1:29 am | by Sudhin Thanawala - Associated Press | News | Comments

A prominent hacker who discovered a way to have automatic teller machines spit out cash and was set to deliver a talk about hacking pacemakers and other wireless implantable medical devices has died in San Francisco, authorities and his employer said.

Weight loss: FDA accepts EnteroMedics' submission of VBLOC neurostim implant

July 26, 2013 12:45 pm | by Mass Device | News | Comments

Minnesota medical devices maker EnteroMedics touted today that the FDA had accepted for review the company's premarket approval submission of the Maestro Rechargeable System's VBLOC implant, a neurostimulation device for treating obesity.   

A Faster Vessel for Charting the Brain

July 26, 2013 12:21 pm | by Morgan Kelly, Princeton University | News | Comments

Princeton University researchers have created “souped up” versions of the calcium-sensitive proteins that for the past decade or so have given scientists an unparalleled view and understanding of brain-cell communication.     

Advertisement

Neuroscientists Plant False Memories in the Brain

July 26, 2013 9:43 am | by Anne Trafton, MIT | News | Comments

The phenomenon of false memory has been well-documented: In many court cases, defendants have been found guilty based on testimony from witnesses and victims who were sure of their recollections, but DNA evidence later overturned the conviction.

EnteroMedics Announces PMA Application for VBLOC Therapy in Obesity Accepted for Review and Filing by FDA

July 25, 2013 4:03 pm | by The Associated Press | News | Comments

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the U.S. FDA has accepted for filing the Company's Premarket Approval application for approval of the Maestro® Rechargeable System's VBLOC® vagal blocking therapy as a treatment for obesity.

The Pulse: How to Patent Bone

July 25, 2013 10:58 am | by Eric Sorensen, Coordinator of Multimedia Development | Videos | Comments

Welcome to the Pulse, brought to you by MDT TV. Today, we’re patenting new biomaterial to make artificial bones, creating pain-free prosthetics, using ultrasound waves to improve your mood, and using magnets to steer stem cells.                 

Stem Cell Research Reveals Clues to Epilepsy Origins and Possible Treatment

July 25, 2013 10:00 am | by Kara Gavin, University of Michigan Health System | News | Comments

A new stem cell-based approach to studying epilepsy has yielded a surprising discovery about what causes one form of the disease, and may help in the search for better medicines to treat all kinds of seizure disorders. The findings, reported by a team of scientists from the University of Michigan Medical School and colleagues, use a technique that could be called "epilepsy in a dish".

Researchers Develop New Approach for Studying Deadly Brain Cancer

July 24, 2013 11:40 am | by University Of Illinois | News | Comments

A team of engineers has developed a three-dimensional hydrogel that more closely mimics conditions in the brain. In a paper in the journal Biomaterials, the researchers describe the new material and their approach, which allows them to selectively tune up or down the malignancy of the cancer cells they study.

Advertisement

Tyrx Receives FDA Clearance for Aigisrx N Antibacterial Envelope

July 24, 2013 10:10 am | by Business Wire | News | Comments

TYRX, Inc. has announced that it has received U.S. Food and Drug Administration (FDA) clearance to market the AIGISRx N Antibacterial Envelope for use with vagus nerve stimulators, which are currently used to treat seizure disorders and depression.

‘Standards’ for Home Healthcare

July 23, 2013 4:44 pm | by Todd Konieczny, Assistant Chief Engineer, Americas Region; Technical Manager, Medical Division, Intertek | Blogs | Comments

The following standard must be met for all medical products intended to be used in the home: IEC 60601-1-11, which is “Medical Electrical Equipment—Part 1-11: General Requirements for Basic Safety and Essential Performance—Collateral Standard: Requirements for Medical Electrical Equipment and Medical Electrical Systems Used in the Home Healthcare Environment.”

Faulty Sensor Forces Infusion Pump Recall

July 23, 2013 3:32 pm | by David Mantey, Executive Editor, MDT | News | Comments

The FDA today announced the recall of the MedStream Programmable Infusion Pump, an implanted device from Switzerland-based manufacturer Medos Internationalused to treat muscle spasms caused by multiple sclerosis, cerebral palsy, or damage to the brain or spinal cord.

Researchers Put Squeeze on Cells to Deliver

July 23, 2013 11:12 am | by National Institute of Biomedical Imaging and Bioengineering | News | Comments

Imagine being able to redirect powerful immune cells to fight cancer. How about reprogramming a diabetic’s skin cell into a cell that could manufacture the insulin their pancreas no longer produces? These are major health problems and medical challenges that may be more achievable with a new fundamental technology that gets vital control molecules into cells faster, safer, and more effectively.

Chips that Mimic the Brain

July 23, 2013 10:08 am | by University of Zurich | News | Comments

No computer works as efficiently as the human brain – so much so that building an artificial brain is the goal of many scientists. Neuroinformatics researchers from the University of Zurich and ETH Zurich have now made a breakthrough in this direction by understanding how to configure so-called neuromorphic chips to imitate the brain's information processing abilities in real-time.

Temperature-Resistant Microchip to be Used for UDI Compliance for Implantables

July 23, 2013 8:30 am | by Business Wire | News | Comments

Digital Angel Corporation, following its recent share exchange with VeriTeQ Acquisition Corporation, announced that VeriTeQ filed a provisional patent with the U.S. Patent and Trademark Office in September 2012 for a microchip that is able to withstand high temperatures in order to make it compatible with the sterilization processes involved in the manufacturing of implantable medical devices.

MS Research Could Help Repair Damage Affecting Nerves

July 22, 2013 11:24 am | by University of Edinburgh | News | Comments

Multiple sclerosis treatments that repair damage to the brain could be developed thanks to new research. A study has shed light on how cells are able to regenerate protective sheaths around nerve fibres in the brain. These sheaths, made up of a substance called myelin, are critical for the quick transmission of nerve signals, enabling vision, sensation and movement.

MicroVention Announces First Trial Enrollment In Their U.S. Clinical Trial Of Its New Dual-Layer Stent For Cerebral Aneurysm Flow Diversion

July 22, 2013 10:00 am | by The Associated Press | News | Comments

MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced earlier last week that they successfully completed their first enrollment in a multi-center, prospective, pivotal U.S. clinical trial to demonstrate the safety and efficacy of its FREDT flow diversion system (FREDT-Flow Re-Direction Endoluminal Device) for treating intracranial aneurysms.

Biosan Medical Receives U.S. Patent for Its Novel Device and Method of Treating the Deadliest Type of Stroke, Subarachnoid Hemorrhage (SAH), and Alzheimer’s Disease

July 22, 2013 9:24 am | by Business Wire | News | Comments

Biosan Medical, an emerging medical device company, announced today that it has been issued U.S. Provisional Patent No. 61,957,293 for its revolutionary Ventritek105® Stroke Treatment Device and Method (“Device & method for CSF auto-transfusion therapy for the treatment of SAH (subarachnoid hemorrhage), Alzheimer’s Disease & other Neuro-Degenerative CNS diseases”).

Zynex Signs Strategic Agreement With Advanced Brain Monitoring, Expands Presence in Sleep Diagnostic Market

July 22, 2013 8:00 am | by The Associated Press | News | Comments

Zynex, Inc. (OTCQB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnostics and cardiac monitoring, announces that it signed a strategic sales, marketing and distribution agreement with California based Advanced Brain Monitoring.

Boston Scientific evaluates neurostimulation in treatment of chronic migraine

July 22, 2013 7:59 am | by Mass Device | News | Comments

Massachusetts medical device giant Boston Scientific announced the start of a new clinical trial to evaluate the use of neurostimulation in treatment of chronic migraines. Boston Scientific's OPTIMISE trial is a randomized, placebo-controlled study assessing occipital nerve stimulation as a novel approach to treating migraines by masking the pain.

The Search for the Best Depression Treatment

July 22, 2013 12:00 am | by Massachusetts Institute of Technology | News | Comments

When someone is diagnosed with depression, patient and doctor often begin a long trial-and-error of different treatments. Sometimes they work, sometimes they don’t, so patients may try several options before finding the best one. But in the future, a brain scan, blood test, or some combination could help guide doctors to the best drugs, or lead them to suggest talk therapy.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading